On the public citation graph
Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection
0 signed · 126 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/s00134-014-3529-8openalex-snapshot
Treatment of Ebola virus disease
inferredcites →https://doi.org/10.1007/s00705-012-1594-2openalex-snapshot
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae
inferredcites →https://doi.org/10.1007/s00705-014-2079-2openalex-snapshot
Comparison of the replication characteristics of vaccinia virus strains Guang 9 and Tian Tan in vivo and in vitro
inferredcites →https://doi.org/10.1016/j.antiviral.2016.01.001openalex-snapshot
Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection
inferredcites →https://doi.org/10.1016/j.micinf.2014.11.012openalex-snapshot
Development of therapeutics for treatment of Ebola virus infection
inferredcites →https://doi.org/10.1016/j.vaccine.2006.09.076openalex-snapshot
Protective efficacy of neutralizing antibodies against Ebola virus infection
inferredcites →https://doi.org/10.1016/j.vaccine.2016.04.029openalex-snapshot
A safe and sensitive enterovirus A71 infection model based on human SCARB2 knock-in mice
inferredcites →https://doi.org/10.1016/j.virol.2004.10.048openalex-snapshot
Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening
inferredcites →https://doi.org/10.1038/78645openalex-snapshot
Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury
inferredcites →https://doi.org/10.1038/nature13777openalex-snapshot
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
inferredcites →https://doi.org/10.1038/srep06881openalex-snapshot
Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus
inferredcites →https://doi.org/10.1038/srep11397openalex-snapshot
Bioluminescent imaging of vaccinia virus infection in immunocompetent and immunodeficient rats as a model for human smallpox
inferredcites →https://doi.org/10.1053/jcpa.2001.0502openalex-snapshot
Pathogenesis of Experimental Ebola Zaire Virus Infection in BALB/c Mice
inferredcites →https://doi.org/10.1056/nejmoa1404505openalex-snapshot
Emergence of Zaire Ebola Virus Disease in Guinea
inferredcites →https://doi.org/10.1056/nejmoa1409838openalex-snapshot
Clinical Care of Two Patients with Ebola Virus Disease in the United States
inferredcites →https://doi.org/10.1073/pnas.1213709109openalex-snapshot
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
inferredcites →https://doi.org/10.1073/pnas.2237038100openalex-snapshot
Ebola virus-like particles protect from lethal Ebola virus infection
inferredcites →https://doi.org/10.1086/514292openalex-snapshot
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
inferredcites →https://doi.org/10.1086/515386openalex-snapshot
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
inferredcites →https://doi.org/10.1093/nar/22.5.888openalex-snapshot
Optimization of primer sequences for mouse scFv repertoire display library construction
inferredcites →https://doi.org/10.1099/jmm.0.036210-0openalex-snapshot
Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β −/− interferon receptor-deficient mice
inferredcites →https://doi.org/10.1126/science.aad5224openalex-snapshot
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
inferredcites →https://doi.org/10.1126/science.aad5788openalex-snapshot
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
inferredcites →https://doi.org/10.1126/scitranslmed.3004582openalex-snapshot
Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates
inferredcites →https://doi.org/10.1126/scitranslmed.aad9875openalex-snapshot
Two-mAb cocktail protects macaques against the Makona variant of Ebola virus
inferredcites →https://doi.org/10.1128/jvi.01239-16openalex-snapshot
An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions
inferredcites →https://doi.org/10.1128/jvi.01296-09openalex-snapshot
Application of Bioluminescence Imaging to the Prediction of Lethality in Vaccinia Virus-Infected Mice
inferredcites →https://doi.org/10.1128/jvi.01810-14openalex-snapshot
Less Is More: Ebola Virus Surface Glycoprotein Expression Levels Regulate Virus Production and Infectivity
inferredcites →https://doi.org/10.1159/000346773openalex-snapshot
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
inferredcites →https://doi.org/10.1186/1742-4690-10-14openalex-snapshot
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
inferredcites →https://doi.org/10.1371/journal.pone.0005547openalex-snapshot
Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
inferredcites →https://doi.org/10.1371/journal.pone.0033392openalex-snapshot
A Novel High-Throughput Vaccinia Virus Neutralization Assay and Preexisting Immunity in Populations from Different Geographic Regions in China
inferredcites →https://doi.org/10.1371/journal.ppat.0030009openalex-snapshot
Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
inferredcites →https://doi.org/10.1371/journal.ppat.1002847openalex-snapshot
The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo
inferredcites →https://doi.org/10.1371/journal.ppat.1004509openalex-snapshot
Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability
inferredcites →https://doi.org/10.1373/clinchem.2015.238204openalex-snapshot
Pseudoparticle Neutralization Assay for Detecting Ebola- Neutralizing Antibodies in Biosafety Level 2 Settings
inferredcites →https://doi.org/10.2217/fvl.09.56openalex-snapshot
Ebolavirus Glycoprotein Structure and Mechanism of Entry
inferredcites →https://doi.org/10.3390/v4091477openalex-snapshot
Mouse Models for Filovirus Infections
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/cti2.1010openalex-snapshot
Vaccinating for natural killer cell effector functions
inferred← citeshttps://doi.org/10.1002/eji.202149470openalex-snapshot
Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients
inferred← citeshttps://doi.org/10.1002/rmv.1963openalex-snapshot
Current status on the development of pseudoviruses for enveloped viruses
inferred← citeshttps://doi.org/10.1007/978-981-99-0113-5_2openalex-snapshot
Assays Based on Pseudotyped Viruses
inferred← citeshttps://doi.org/10.1007/978-981-99-0113-5_3openalex-snapshot
Application of Pseudotyped Viruses
inferred← citeshttps://doi.org/10.1007/978-981-99-0113-5_6openalex-snapshot
Pseudotyped Viruses for Marburgvirus and Ebolavirus
inferred← citeshttps://doi.org/10.1007/s00216-021-03317-4openalex-snapshot
Antibody affinity as a driver of signal generation in a paper-based immunoassay for Ebola virus surveillance
inferred← citeshttps://doi.org/10.1016/j.apsb.2017.08.003openalex-snapshot
Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors
inferred← citeshttps://doi.org/10.1016/j.apsb.2018.01.006openalex-snapshot
Synthesis and biological evaluation of novel tricyclic matrinic derivatives as potential anti-filovirus agents
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105196openalex-snapshot
Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage
inferred← citeshttps://doi.org/10.1016/j.cell.2021.02.026openalex-snapshot
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
inferred← citeshttps://doi.org/10.1016/j.coi.2018.05.001openalex-snapshot
The structural basis for filovirus neutralization by monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.02.061openalex-snapshot
Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.113735openalex-snapshot
The therapeutic potential of mRNA-encoded SFTSV human monoclonal antibody encapsulated lipid nanoparticle in vivo
inferred← citeshttps://doi.org/10.1016/j.jim.2018.06.002openalex-snapshot
A novel Ebola virus antibody-dependent cell-mediated cytotoxicity (Ebola ADCC) assay
inferred← citeshttps://doi.org/10.1016/j.micres.2022.126993openalex-snapshot
Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
inferred← citeshttps://doi.org/10.1016/j.procbio.2023.01.018openalex-snapshot
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
inferred← citeshttps://doi.org/10.1016/j.smim.2023.101842openalex-snapshot
Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.10.007openalex-snapshot
Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system
inferred← citeshttps://doi.org/10.1016/j.virol.2021.02.003openalex-snapshot
On the road to ending the COVID-19 pandemic: Are we there yet?
inferred← citeshttps://doi.org/10.1016/s0140-6736(23)00048-xopenalex-snapshot
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial
inferred← citeshttps://doi.org/10.1016/s1473-3099(18)30165-8openalex-snapshot
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study
inferred← citeshttps://doi.org/10.1021/acsinfecdis.1c00096openalex-snapshot
Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone
inferred← citeshttps://doi.org/10.1021/acsnano.0c06836openalex-snapshot
Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.1038/s41392-021-00759-1openalex-snapshot
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients
inferred← citeshttps://doi.org/10.1038/s41467-018-06741-wopenalex-snapshot
Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
inferred← citeshttps://doi.org/10.1038/s41541-019-0109-5openalex-snapshot
Rabies-based vaccine induces potent immune responses against Nipah virus
inferred← citeshttps://doi.org/10.1038/s41541-021-00280-0openalex-snapshot
Durable natural killer cell responses after heterologous two-dose Ebola vaccination
inferred← citeshttps://doi.org/10.1038/s41541-024-00877-1openalex-snapshot
Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus
inferred← citeshttps://doi.org/10.1038/s41590-018-0233-9openalex-snapshot
Antibody-mediated protection against Ebola virus
inferred← citeshttps://doi.org/10.1038/s41591-019-0602-4openalex-snapshot
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
inferred← citeshttps://doi.org/10.1038/s41598-018-26822-6openalex-snapshot
Development of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus
inferred← citeshttps://doi.org/10.1038/s41598-020-73960-xopenalex-snapshot
Development of an antibody-dependent cellular cytotoxicity reporter assay for measuring anti-Middle East Respiratory Syndrome antibody bioactivity
inferred← citeshttps://doi.org/10.1038/s41598-025-23919-7openalex-snapshot
Bivalent SARS-CoV-2 spike immunization with non-replicative antibiotic resistance-free DNA vaccine induces immunity to multiple virus variants
inferred← citeshttps://doi.org/10.1080/22221751.2019.1571871openalex-snapshot
Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities
inferred← citeshttps://doi.org/10.1080/22221751.2020.1743767openalex-snapshot
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
inferred← citeshttps://doi.org/10.1080/22221751.2024.2432366openalex-snapshot
A pan-orthoebolavirus neutralizing antibody encoded by mRNA effectively prevents virus infection
inferred← citeshttps://doi.org/10.1089/vim.2019.0207openalex-snapshot
B Cell Activation and Response Regulation During Viral Infections
inferred← citeshttps://doi.org/10.1093/cid/ciae215openalex-snapshot
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without Human Immunodeficiency Virus in Africa
inferred← citeshttps://doi.org/10.1093/immadv/ltaa007openalex-snapshot
Recent advances in immunotherapies against infectious diseases
inferred← citeshttps://doi.org/10.1093/infdis/jiy377openalex-snapshot
Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate
inferred← citeshttps://doi.org/10.1093/infdis/jiz657openalex-snapshot
Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination
inferred← citeshttps://doi.org/10.1097/bs9.0000000000000047openalex-snapshot
Potential benefits, mechanisms, and uncertainties of convalescent plasma therapy for COVID-19
inferred← citeshttps://doi.org/10.1097/id9.0000000000000053openalex-snapshot
Potential of Antibody-Dependent Cellular Cytotoxicity in Acute and Recovery Phases of SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.1101/2024.07.23.604823openalex-snapshot
Activating FcγRs on monocytes are necessary for optimal Mayaro virus clearance
inferred← citeshttps://doi.org/10.1111/1348-0421.13036openalex-snapshot
Development of a reporter gene assay for antibody dependent cellular cytotoxicity activity determination of anti‐rabies virus glycoprotein antibodies
inferred← citeshttps://doi.org/10.1111/imcb.12312openalex-snapshot
The protective potential of Fc‐mediated antibody functions against influenza virus and other viral pathogens
inferred← citeshttps://doi.org/10.1111/imm.12861openalex-snapshot
Prospects from systems serology research
inferred← citeshttps://doi.org/10.1126/sciimmunol.aav5062openalex-snapshot
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
inferred← citeshttps://doi.org/10.1128/jvi.00685-24openalex-snapshot
Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity
inferred← citeshttps://doi.org/10.1128/jvi.01865-18openalex-snapshot
A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model
inferred← citeshttps://doi.org/10.1128/jvi.01884-19openalex-snapshot
A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques
inferred← citeshttps://doi.org/10.1128/spectrum.02212-21openalex-snapshot
TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein
inferred← citeshttps://doi.org/10.1136/bmjresp-2021-001017openalex-snapshot
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
inferred← citeshttps://doi.org/10.1172/jci132438openalex-snapshot
Ebola virus glycoprotein stimulates IL-18–dependent natural killer cell responses
inferred← citeshttps://doi.org/10.1186/s12964-023-01104-5openalex-snapshot
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
inferred← citeshttps://doi.org/10.1371/journal.ppat.1007375openalex-snapshot
An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus
inferred← citeshttps://doi.org/10.1371/journal.ppat.1012944openalex-snapshot
Interaction of the endogenous antibody response with activating FcγRs enhance control of Mayaro virus through monocytes
inferred← citeshttps://doi.org/10.2147/btt.s259069openalex-snapshot
Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
inferred← citeshttps://doi.org/10.3389/fcimb.2024.1353971openalex-snapshot
Natural products as a source of Coronavirus entry inhibitors
inferred← citeshttps://doi.org/10.3389/fimmu.2018.01428openalex-snapshot
The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
inferred← citeshttps://doi.org/10.3389/fimmu.2018.03172openalex-snapshot
Peste des Petits Ruminants Virus Fusion and Hemagglutinin Proteins Trigger Antibody-Dependent Cell-Mediated Cytotoxicity in Infected Cells
inferred← citeshttps://doi.org/10.3389/fimmu.2019.00548openalex-snapshot
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
inferred← citeshttps://doi.org/10.3389/fimmu.2019.01604openalex-snapshot
Poly-γ-Glutamic Acid Complexed With Alum Induces Cross-Protective Immunity of Pandemic H1N1 Vaccine
inferred← citeshttps://doi.org/10.3389/fimmu.2021.682120openalex-snapshot
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors
inferred← citeshttps://doi.org/10.3389/fimmu.2021.721328openalex-snapshot
Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection
inferred← citeshttps://doi.org/10.3389/fimmu.2021.788203openalex-snapshot
FcγR Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations
inferred← citeshttps://doi.org/10.3389/fimmu.2022.857481openalex-snapshot
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis
inferred← citeshttps://doi.org/10.3389/fimmu.2022.929895openalex-snapshot
Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
inferred← citeshttps://doi.org/10.3389/fimmu.2022.964398openalex-snapshot
The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1183727openalex-snapshot
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1772257openalex-snapshot
Fc effector functions in RNA viral infections: mechanisms of antiviral immunity and implications for vaccine design
inferred← citeshttps://doi.org/10.3390/antib14010022openalex-snapshot
Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies
inferred← citeshttps://doi.org/10.3390/microorganisms9081744openalex-snapshot
SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes
inferred← citeshttps://doi.org/10.3390/v12060582openalex-snapshot
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
inferred← citeshttps://doi.org/10.3390/v15071548openalex-snapshot
A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
inferred← citeshttps://doi.org/10.3390/vaccines10060884openalex-snapshot
NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in Africans
inferred← citeshttps://doi.org/10.3390/vaccines11091404openalex-snapshot
Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
inferred← citeshttps://doi.org/10.3390/vaccines11121758openalex-snapshot
Inactivated Recombinant Rabies Virus Displaying the Nipah Virus Envelope Glycoproteins Induces Systemic Immune Responses in Mice
inferred← citeshttps://doi.org/10.3390/vaccines12050497openalex-snapshot
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial
inferred← citeshttps://doi.org/10.3390/vaccines13030262openalex-snapshot
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults
inferred← citeshttps://doi.org/10.36233/0372-9311-684openalex-snapshot
Application of the pseudovirus-based neutralization assay in the search for new antiviral drugs
inferred← citeshttps://doi.org/10.4049/jimmunol.1700827openalex-snapshot
Ebola Immunity: Gaining a Winning Position in Lightning Chess
inferred← citeshttps://doi.org/10.4049/jimmunol.2000191openalex-snapshot
Exploiting Pre-Existing CD4+ T Cell Help from Bacille Calmette–Guérin Vaccination to Improve Antiviral Antibody Responses
inferred← citeshttps://doi.org/10.4103/1995-7645.291408openalex-snapshot
Convalescent plasma: A potential therapeutic option for COVID-19 patients
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.